Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

Market Cap	11.97B
Revenue (ttm)	1.39B
Net Income (ttm)	410.59M
Shares Out	70.00M
EPS (ttm)	5.87
PE Ratio	29.15
Forward PE	27.00
Dividend	3.06 (1.79%)
Ex-Dividend Date	Mar 5, 2025

Volume	44,556
Average Volume	59,625
Open	170.40
Previous Close	170.20
Day's Range	169.80 - 171.20
52-Week Range	134.00 - 202.40
Beta	1.05
RSI	55.56
Earnings Date	Aug 11, 2025

About TADAWUL:4015

Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4015

Financial Performance

In 2024, TADAWUL:4015's revenue was 1.32 billion, an increase of 19.77% compared to the previous year's 1.10 billion. Earnings were 356.52 million, an increase of 21.93%.